- Page 1
- Page 2 - Page 3 - Page 4 - Page 5 - Page 6 - Page 7 - Page 8 - Page 9 - Page 10 - Page 11 - Page 12 - Page 13 - Page 14 - Page 15 - Page 16 - Page 17 - Page 18 - Page 19 - Page 20 - Page 21 - Page 22 - Page 23 - Page 24 - Page 25 - Page 26 - Page 27 - Page 28 - Page 29 - Page 30 - Page 31 - Page 32 - Page 33 - Page 34 - Page 35 - Page 36 - Page 37 - Page 38 - Page 39 - Page 40 - Page 41 - Page 42 - Page 43 - Page 44 - Page 45 - Page 46 - Page 47 - Page 48 - Page 49 - Page 50 - Page 51 - Page 52 - Page 53 - Page 54 - Page 55 - Page 56 - Page 57 - Page 58 - Page 59 - Page 60 - Page 61 - Page 62 - Page 63 - Page 64 - Page 65 - Page 66 - Page 67 - Page 68 - Page 69 - Page 70 - Page 71 - Page 72 - Page 73 - Page 74 - Page 75 - Page 76 - Page 77 - Page 78 - Page 79 - Page 80 - Page 81 - Page 82 - Page 83 - Page 84 - Page 85 - Page 86 - Page 87 - Page 88 - Page 89 - Page 90 - Page 91 - Page 92 - Page 93 - Page 94 - Page 95 - Page 96 - Page 97 - Page 98 - Page 99 - Page 100 - Flash version © UniFlip.com |
Anxiety & Depression
Aron Test for Screen Anxiolytic Substances
Anxiety & Depression • Aron Test for Screen Anxiolytic Substances
Specifications
cage Materials Dimensions (H x W x D) shock shock Delivery white, transparent plastic and stainless steel 16 x 25 x 18 cm (6.3 x 9.8 x 7 in) 0-3 ma, timer 0-10 sec, square pulse footswitch
Ordering Information
Order # 76-0006 Model Le830* Product aron test box
* shock generator (76-0159) must be ordered separately.
RefeRences
key features
} An elegant and economical solution for screening
anxiolytic drugs in mice
} Punishment based conflict test } Shock with adjustable intensity
parameters measured
Andreasen JT et al. (2013) A combined ⁸7 nicotinic acetylcholine receptor agonist and monoamine reuptake inhibitor, NS9775, represents a novel profile with potential benefits in emotional and cogniHYPERLINK tive disturbances. Neuropharmacology, Volume 73, October 2013, Pages 183–191. Chlon-Rzepa G et al. (2013) New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation. Pharmacological Reports 65: 1529. Hache G et al. (2012) Antinociceptive effects of fluoxetine in a mouse modelof anxiety/ depression. NeuroReport 2012, 23:525–529. Bourin M et al. (2010) Implication of 5-HT2 receptor subtypes in the mechanism of action of the GABAergic compound etifoxine in the ”four-plate” test in Swiss mice. Behavioural Brain Res. 208(2):352-358. Foreman MM et al. (2009) Anxiolytic effects of lamotrigine and JZP-4 in the elevated plus maze and in the four plate conflict test. Eur J Pharmacol. 602(2-3):316-20. Jacobsen JP et al. (2008) SK3 K+ channel-deficient mice have enhanced dopamine and serotonin release and altered emotional behaviors. Genes Brain Behav. 7(8):836-48. Masse F et al. (2008) Anxiolytic-like effects of DOI microinjections into the hippocampus (but not the amygdala nor the PAG) in the mice four plates test. Behav. Brain Res. 188(2):291-297.
} Number of punished crossings
components included
} Aron box } Control unit footswitch } Cables and connectors } Instruction manual } 2 year warranty
The Aron Test, or Four Plates Test, is an animal model of anxiety in which the exploration of the novel surroundings is suppressed by the delivery of a mild electric foot shock. The apparatus consists of a cage floor with four identical rectangular metal plates (8 x 11 cm) (3 x 4 in) separated from one another by a gap of 4 mm (0.2 in). The plates are connected to a shocker unit that can generate electric foot shocks. Following the habituation period, the animal is subjected to an electric shock when crossing (transition) from one plate to another, i.e. two legs on one plate and two legs on another. Boissier et al. 1968 described this test first. The number of punished crossings is generally calculated for a period of 60 seconds. A substance with anxiolytic properties induces an increase in the number of punished passages.
76
www.coulbourn.com
•
www.panlab.com
|